Search

Your search keyword '"Hellmut Samonigg"' showing total 223 results

Search Constraints

Start Over You searched for: Author "Hellmut Samonigg" Remove constraint Author: "Hellmut Samonigg"
223 results on '"Hellmut Samonigg"'

Search Results

101. A Phase II Trial of Weekly High-Dose Folinic Acid and 5-Fluorouracil in Combination with Epirubicin as Salvage Chemotherapy in Advanced Breast Cancer

102. Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial

103. NEMO expression in human hepatocellular carcinoma and its association with clinical outcome

104. Single nucleotide polymorphisms of integrin alpha-2 and beta-3 genes are not associated with relapse-free and overall survival in colorectal cancer patients

105. Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck

106. The presence of immunosuppressive ‘p15E-like’ factors in the serum and urine of patients suffering from malign and benign breast tumours

107. Novel immunofluorescence protocol for multimarker assessment of putative disseminating breast cancer stem cells

108. Association of hypoxia-inducible factor 1-alpha gene polymorphisms and colorectal cancer prognosis

109. Rapid and reliable detection of LINE-1 hypomethylation using high-resolution melting analysis

110. Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk

111. Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?

112. Association of interleukin-10 gene variation with breast cancer prognosis

113. Endocrine therapy plus zoledronic acid in premenopausal breast cancer

114. Diagnostic image analysis of malignant melanoma in in vivo confocal laser-scanning microscopy: a preliminary study

115. High quality assessment of DNA methylation in archival tissues from colorectal cancer patients using quantitative high-resolution melting analysis

116. [The use of erythropoiesis-stimulating proteins in anemic patients with malignant diseases]

117. Integrin alpha-2 and beta-3 gene polymorphisms and colorectal cancer risk

118. Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy

119. Optimization of Diagnostic Elisa - Based Tests for the Detection of Auto-Antibodies Against Tumor Antigens in Human Serum

120. Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy

121. Discrimination of actinic keratoses from normal skin with reflectance mode confocal microscopy

123. Comparison of acute effects of anthracyclines on cardiac electrophysiological parameters of isolated guinea-pig hearts

124. 4′-O-Tetrahydropyranyl-doxorubicin in advanced breast cancer: a phase II study

125. Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a

126. The potential risk of neoadjuvant chemotherapy in breast cancer patients--results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07)

127. Pathologic complete response with six compared with three cycles of neoadjuvant epirubicin plus docetaxel and granulocyte colony-stimulating factor in operable breast cancer: results of ABCSG-14

128. A multigenic approach to predict breast cancer risk

129. Sensitivity and specificity of confocal laser-scanning microscopy for in vivo diagnosis of malignant skin tumors

130. Assessing symptoms of terminally-ill patients by different raters: a prospective study

131. Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk

132. Critical evaluation of real-time reverse transcriptase-polymerase chain reaction for the quantitative detection of cytokeratin 20 mRNA in colorectal cancer patients

133. Comparison of two methods for enumerating circulating tumor cells in carcinoma patients

134. Implementation of a palliative care team in an Austrian university hospital

135. Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial

137. Association of disease progression and poor overall survival with detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer

140. Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer

141. Change of HER-2/neu status in a subset of distant metastases from breast carcinomas

142. The course of serum HER-2/neu levels as an independent prognostic factor for survival in metastatic breast cancer

143. Changes in psychological distress of women with breast cancer in long-term remission and their husbands

144. The 870GA polymorphism of the cyclin D1 gene is not associated with breast cancer

145. The L10P polymorphism of the transforming growth factor-beta 1 gene is not associated with breast cancer risk

146. The 825CT polymorphism of the G-protein beta-3 subunit gene (GNB3) and breast cancer

147. High p27Kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage breast cancer receiving adjuvant treatment with tamoxifen plus goserelin

148. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk

149. P-0197 Common VEGF Gene Polymorphisms are Not Associated With Relapse-Free Survival in Colorectal Cancer Patients

150. Varying Amounts of Tumor Cells in the Bone Marrow of Patients with Nonmetastatic Colorectal Cancer

Catalog

Books, media, physical & digital resources